基于“脑肠轴”理论探讨从肝脾论治化疗相关性便秘的作用机制
Exploring the Mechanism of Treating Chemotherapy-Related Constipation from the Perspective of Liver and Spleen Based on the Brain-Gut Axis Theory
DOI: 10.12677/tcm.2025.1412782, PDF,   
作者: 桑珊珊, 赵立娜, 李莹莹, 管晓晖, 杨佩颖*:天津中医药大学第一附属医院,天津;国家中医针灸临床医学研究中心,天津;天津市中医肿瘤研究所,天津
关键词: 化疗相关性便秘肝脾脑肠轴作用机制Chemotherapy-Related Constipation Liver and Spleen Brain-Gut Axis Mechanism of Action
摘要: 化疗相关性便秘(CRC)是恶性肿瘤患者常见且严重影响生活质量的不良反应,其发病机制尚未完全阐明,治疗手段亦有限。本文基于“脑肠轴”理论,系统探讨CRC的现代病理机制与中医“肝脾失调”核心病机之间的内在联系。国内外诸多研究发现,CRC的发生与脑肠轴“四通道”即肠道菌群失衡、肠神经系统损伤、迷走神经–下丘脑–垂体–肾上腺轴亢进及免疫炎症反应密切相关。中医辨证认为,CRC以“肝郁脾虚”之证最为常见,肝失疏泄、脾失健运,致气机不畅、传导失司,与该病的发病机制相契合,人是一个有机整体,故心肠、脑、脾、肝相互沟通联络。文章提出“疏肝理脾、调畅气机”为中医治疗CRC的基本法则,并通过中药、针灸等手段调节脑肠轴功能,改善肠道动力与神经递质水平,为中西医结合干预CRC提供新思路与理论依据。
Abstract: Chemotherapy-related constipation (CRC) is a common adverse reaction that seriously affects the quality of life of patients with malignant tumors, and its pathogenesis has not been fully elucidated, and treatment options are limited. Based on the “brain-gut axis” theory, this paper systematically explores the internal relationship between the modern pathological mechanism of CRC and the core pathogenesis of “liver and spleen disorder” in traditional Chinese medicine. It was found that the occurrence of CRC was closely related to the imbalance of intestinal flora, enteric nervous system injury, vagus nerve-hypothalamic-pituitary-adrenal axis hyperactivity, and immune inflammatory response. Traditional Chinese medicine syndrome differentiation believes that CRC is more common with the syndrome of “liver depression and spleen deficiency”, with liver loss of drainage and spleen loss of health, resulting in poor qi and conduction failure, which is consistent with the dysfunction of the brain-intestinal axis. This paper proposes that “relaxing the liver and regulating the spleen, and regulating the qi machine” is the basic rule of traditional Chinese medicine in the treatment of CRC, and regulates the function of the brain-gut axis through traditional Chinese medicine, acupuncture and other means, improves intestinal motility and neurotransmitter levels, and provides new ideas and theoretical basis for the intervention of integrated traditional Chinese and Western medicine in CRC.
文章引用:桑珊珊, 赵立娜, 李莹莹, 管晓晖, 杨佩颖. 基于“脑肠轴”理论探讨从肝脾论治化疗相关性便秘的作用机制[J]. 中医学, 2025, 14(12): 5443-5449. https://doi.org/10.12677/tcm.2025.1412782

参考文献

[1] McQuade, R.M., Stojanovska, V., Abalo, R., Bornstein, J.C. and Nurgali, K. (2016) Chemotherapy-induced Constipation and Diarrhea: Pathophysiology, Current and Emerging Treatments. Frontiers in Pharmacology, 7, Article 414. [Google Scholar] [CrossRef] [PubMed]
[2] 中国慢性便秘诊治指南(2013, 武汉) [J]. 胃肠病学, 2013, 18(10): 605-612.
[3] Carabotti, M., Scirocco, A., Maselli, M.A., et al. (2015) The Gut-Brain Axis: Interactions between Enteric Microbiota, Central and Enteric Nervous Systems. Annals of Gastroenterology, 28, 203-209.
[4] 刘娅薇, 惠华英, 谭周进. 脑肠轴传输中的胃肠肽类激素[J]. 世界华人消化杂志, 2019, 27(16): 1007-1012.
[5] Alexander, J.L., Wilson, I.D., Teare, J., Marchesi, J.R., Nicholson, J.K. and Kinross, J.M. (2017) Gut Microbiota Modulation of Chemotherapy Efficacy and Toxicity. Nature Reviews Gastroenterology & Hepatology, 14, 356-365. [Google Scholar] [CrossRef] [PubMed]
[6] Liu, H., Wang, J., He, T., Becker, S., Zhang, G., Li, D., et al. (2018) Butyrate: A Double-Edged Sword for Health? Advances in Nutrition, 9, 21-29. [Google Scholar] [CrossRef] [PubMed]
[7] Escalante, J., McQuade, R.M., Stojanovska, V. and Nurgali, K. (2017) Impact of Chemotherapy on Gastrointestinal Functions and the Enteric Nervous System. Maturitas, 105, 23-29. [Google Scholar] [CrossRef] [PubMed]
[8] 刘启鸿, 胡剑云, 王宁馨, 等. 5-羟色胺信号系统的研究概况[J]. 医学综述, 2021, 27(11): 2099-2103.
[9] Esposito, G., Cirillo, C., Sarnelli, G., De Filippis, D., D’Armiento, F.P., Rocco, A., et al. (2007) Enteric Glial-Derived S100B Protein Stimulates Nitric Oxide Production in Celiac Disease. Gastroenterology, 133, 918-925. [Google Scholar] [CrossRef] [PubMed]
[10] 王亚梅, 贾漪涛, 李中信. 肠神经胶质细胞在肠道功能与肠道疾病中的作用[J]. 世界华人消化杂志, 2020, 28(19): 979-985.
[11] Foong, D., Zhou, J., Zarrouk, A., Ho, V. and O’Connor, M.D. (2020) Understanding the Biology of Human Interstitial Cells of Cajal in Gastrointestinal Motility. International Journal of Molecular Sciences, 21, Article 4540. [Google Scholar] [CrossRef] [PubMed]
[12] Labanski, A., Langhorst, J., Engler, H. and Elsenbruch, S. (2020) Stress and the Brain-Gut Axis in Functional and Chronic-Inflammatory Gastrointestinal Diseases: A Transdisciplinary Challenge. Psychoneuroendocrinology, 111, Article 104501. [Google Scholar] [CrossRef] [PubMed]
[13] Bertollo, A.G., Santos, C.F., Bagatini, M.D. and Ignácio, Z.M. (2025) Hypothalamus-Pituitary-Adrenal and Gut-Brain Axes in Biological Interaction Pathway of the Depression. Frontiers in Neuroscience, 19, Article 1541075. [Google Scholar] [CrossRef] [PubMed]
[14] Rusch, J.A., Layden, B.T. and Dugas, L.R. (2023) Signalling Cognition: The Gut Microbiota and Hypothalamic-Pituitary-Adrenal Axis. Frontiers in Endocrinology, 14, Article 1130689. [Google Scholar] [CrossRef] [PubMed]
[15] Dmytriv, T.R., Storey, K.B. and Lushchak, V.I. (2024) Intestinal Barrier Permeability: The Influence of Gut Microbiota, Nutrition, and Exercise. Frontiers in Physiology, 15, Article 1380713. [Google Scholar] [CrossRef] [PubMed]
[16] Feng, X., Jia, M., Cai, M., Zhu, T., Hashimoto, K. and Yang, J. (2025) Central-Peripheral Neuroimmune Dynamics in Psychological Stress and Depression: Insights from Current Research. Molecular Psychiatry, 30, 4881-4898. [Google Scholar] [CrossRef] [PubMed]
[17] 王超然, 周琴, 杨莹, 等. 恶性肿瘤化疗相关性便秘的中医辨治策略分析[J]. 中医药导报, 2019, 25(8): 37-40.
[18] 张声生, 沈洪, 张露, 等. 便秘中医诊疗专家共识意见(2017) [J]. 中医杂志, 2017, 58(15): 1345-1350.
[19] 唐容川. 金匮要略浅注补正[M]. 太原: 山西科学技术出版社, 2013.
[20] 黄雅懔. 逍遥散对焦虑症大鼠胃肠道Ghrelin和Obestatin含量表达的调节作用[D]: [硕士学位论文]. 北京: 北京中医药大学, 2016.
[21] Hao, W., Wu, J., Yuan, N., Gong, L., Huang, J., Ma, Q., et al. (2021) Xiaoyaosan Improves Antibiotic-Induced Depressive-Like and Anxiety-Like Behavior in Mice through Modulating the Gut Microbiota and Regulating the NLRP3 Inflammasome in the Colon. Frontiers in Pharmacology, 12, Article 619103. [Google Scholar] [CrossRef] [PubMed]
[22] 陈嫒, 郑于林, 王芳, 等. 基于RhoA/ROCK信号通路探讨逍遥散对肝郁脾虚证大鼠胃肠动力的影响[J]. 中国实验方剂学杂志, 2022, 28(22): 1-6.
[23] 亚东, 都业馨, 王丽, 等. 穴位注射黄芪注射液治疗气虚型慢传输型便秘[J]. 长春中医药大学学报, 2018, 34(5): 925-927.
[24] 施旭光, 翟理祥, 邓淙友, 等. 补中益气汤的现代研究进展[J]. 山西中医学院学报, 2012, 13(3): 152-154.
[25] 李晓红, 陈家旭. 肝主疏泄与脑-肠轴的相关性探讨[J]. 中医杂志, 2010, 51(10): 872-874.
[26] 何岳珍, 陈静, 史正刚, 等. 脾主运化理论与肠道微生态相关性研究[J]. 中医儿科杂志, 2023, 19(6): 100-103.
[27] Zhang, F., Chen, H., Zhang, R., Liu, Y., Kong, N., Guo, Y., et al. (2020) 5-Fluorouracil Induced Dysregulation of the Microbiome-Gut-Brain Axis Manifesting as Depressive Like Behaviors in Rats. Biochimica et Biophysica ActaMolecular Basis of Disease, 1866, Article 165884. [Google Scholar] [CrossRef] [PubMed]
[28] 耿华擎, 陈萌. 基于“脑-肠轴”理论探讨功能性便秘的机制及中医药治疗思路[J]. 实用中医内科杂志, 2025, 39(5): 10-15.
[29] 胡欢, 蔡愈. 加味大柴胡汤治疗恶性肿瘤化疗后便秘的临床效果分析[J]. 现代医学与健康研究电子杂志, 2023, 7(13): 102-104.
[30] 段靓钰, 李洪智, 温彩云. 加味大柴胡汤治疗恶性肿瘤化疗后便秘疗效观察[J]. 实用中医药杂志, 2018, 34(12): 1437-1438.
[31] 赵东陆, 宋航, 邢琦, 等. 麻仁清润便通方联合乳果糖治疗肿瘤化疗并发便秘对VIP、CCRP、MTL水平的影响[J]. 临床和实验医学杂志, 2022, 21(15): 1618-1622.
[32] 周娟, 田广玉. 四磨汤联合莫沙必利治疗化疗相关性便秘疗效观察[J]. 中国实用医药, 2015, 10(26): 156-157.
[33] 杨惠宇. 温针灸改善大肠癌术后化疗患者便秘及焦虑、抑郁的临床研究[D]: [硕士学位论文]. 兰州: 甘肃中医药大学, 2021.